We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,869

Network interference - a legal guide to the commercial risks and rewards of the social media phenomenon
  • Reed Smith LLP
  • USA, European Union, Global, United Kingdom
  • April 22 2014

Social media is a revolution in the way in which corporations communicate with consumers. This White Paper will help you to maximise the huge


Lipitor MDL Court Grants Pfizer’s Omnibus Summary Judgment Motion: No Evidence of Causation
  • Reed Smith LLP
  • USA
  • January 9 2017

For those of us who spend large chunks of our professional lives in mass tort MDLs, expressions like “settlement Inventory” are ubiquitous. It is too


FDA Releases Guidance on Cybersecurity and Medical Devices
  • Reed Smith LLP
  • USA
  • January 6 2017

The FDA represents the latest federal agency to show a focus on cybersecurity issues with the release December 28 of new guidance. While the prospect


Guest Post - Failure to Warn Claim Dead on Arrival Without Testimony from Prescribing Physician
  • Reed Smith LLP
  • USA
  • January 3 2017

This is a guest post from Michael Salimbene, an associate at Reed Smith. It’s about learned intermediary causation, and the need for prescriber


“Regulatory Causation” Roundup
  • Reed Smith LLP
  • USA
  • January 10 2017

Last week’s Westlaw search (that’s one way we find the cases we discuss in the Blog) brought a blast from the past - a case almost three years old


Decision Limiting Duties regarding Automated External Defibrillators Does Not Shock The Conscience
  • Reed Smith LLP
  • USA
  • December 30 2016

Ponder the following: A man attends an exercise class at a facility run by a local religious institution. Assume that he belonged to this facility


SDNY Applies Preemption in Favor of Branded Drug
  • Reed Smith LLP
  • USA
  • January 4 2017

Yesterday we commenced the dreary process of taking down the Christmas decorations. The German nutcrackers slid back into their cartons. Stockings


OIG Issues Annual Solicitation of Suggestions for New Fraud Alerts, Anti-Kickback Safe Harbors
  • Reed Smith LLP
  • USA
  • January 11 2017

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) is inviting public recommendations for new or modified


Medical Causation Experts Pass Daubert Test, But Cannot Opine on Plaintiff’s Lack of Capacity to Sign Release
  • Reed Smith LLP
  • USA
  • January 11 2017

We typically write about product liability cases, not medical malpractice actions. But the two are not mutually exclusive, and similar issues arise


CMS to Host Call on Transitioning Physician Quality Reporting to MIPS (Jan. 24)
  • Reed Smith LLP
  • USA
  • January 11 2017

On January 24, 2017, CMS is hosting a call to discuss how to complete the final reporting period for the “legacy” Medicare physician quality